✦ LIBER ✦

Reducing nephrotoxicity in pediatric liver transplant recipients with low-dose tacrolimus and mycophenolate mofetil

✍ Scribed by N.R. Barshes; I. Chang; I.W. Udell; T.C. Lee; C.A. O’Mahony; S.J. Karpen; B.A. Carter; J.A. Goss

Book ID: 116702256
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 45 KB
Volume: 130
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2005.11.242

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary immunosuppression with tacrolimu

Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients

✍ S. Yeung; W.K. Tsang; K.L. Tong; S.H. Wong; W. Lee; H.L. Tang; H.W.H. Chan; A.Y. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Mycophenolate mofetil overlap in liver t

Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity

✍ J Torras; J Figueras; C Lama; J Fabregat; E Ramos; A Rafecas; S Gil-Vernet; D Pa 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Reduced-Dose Tacrolimus with Mycophenola

Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study

✍ K. Boudjema; C. Camus; F. Saliba; Y. Calmus; E. Salamé; G. Pageaux; C. Ducerf; C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Pharmacokinetics, efficacy, and safety o

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients

✍ Björn Nashan; Faouzi Saliba; Francois Durand; Rafael Barcéna; Jose Ignacio Herre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepati

Steroid-free regimen with daclizumab, my

Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients

✍ J Figueras; A Bernardos; M Prieto; M Gómez; A Rimola; J Ortiz de Urbina; V Cuerv 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Pharmacokinetics of mycophenolate mofeti

Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine

✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req